Arcturus Therapeutics Holdings Inc (NAS:ARCT)
$ 18.36 -0.47 (-2.5%) Market Cap: 497.32 Mil Enterprise Value: 302.30 Mil PE Ratio: 0 PB Ratio: 1.90 GF Score: 76/100

Arcturus Therapeutics Holdings Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 11:00PM GMT
Release Date Price: $32.95 (+0.92%)
Unidentified Participant

Hello. Welcome to the 42nd Annual JPMorgan Healthcare Conference. My name is [Edwin Zayne] I'm a member of the JPMorgan Healthcare team. Today, I would like to introduce you to the team from Arcturus Therapeutics. Please join me in welcoming our presenter, Joe Payne, who is the President and CEO of Arcturus.

Joseph Payne
Arcturus Therapeutics Holdings Inc - President, Chief Executive Officer, Director

All right. Thank you. Another year has gone by everyone. It was an exciting one for Arcturus. It's be happy to summarize. Some of the progress we've made this year has been extraordinary, very, very pleased with our team and what we've done. It's exciting to be with you. And we have a lot of friends and colleagues here as well that we work with. So I'm glad we could share this together. Arcturus has a messenger RNA medicines and vaccines company based in San Diego, we have next generation technologies. So don't kid yourself. We are different with respect to our science. We are now global with a late-stage clinical company for sure. We have an

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot